- Featured Product
- KD/KO Validated
TGF-beta 2-Specific Antibody
TGF-beta 2-Specific Polyclonal Antibody for IF, IHC, WB, ELISA
Cat no : 19999-1-AP
BSC 1 cell growth inhibitor, Cetermin, G TSF, Polyergin, TGF beta 2, TGF beta2, TGFB2, TGF-beta 2, TGFβ2
|Positive WB detected in||K-562 cells, HeLa cells, A549 cells, mouse lung tissue|
|Positive IHC detected in||human breast cancer tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||HeLa cells|
|Western Blot (WB)||WB : 1:500-1:1000|
|Immunohistochemistry (IHC)||IHC : 1:50-1:500|
|Immunofluorescence (IF)||IF : 1:50-1:500|
|Sample-dependent, check data in validation data gallery|
19999-1-AP targets TGF-beta 2-Specific in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse samples.
|Tested Reactivity||human, mouse|
|Cited Reactivity||human, mouse, rat|
|Host / Isotype||Rabbit / IgG|
|Full Name||transforming growth factor, beta 2|
|Calculated molecular weight||48 kDa|
|Observed molecular weight||48 kDa|
|GenBank accession number||NM_003238|
|Gene ID (NCBI)||7042|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
Tranforming growth factor beta-2 (TGFB2), also named G-TSF, BSC-1 cell growth inhibitor, Polyergin and Cetermin, belongs to the TGF-beta family. TGFB2 is a secreted protein and contains a 19aa signal peptides at its N-terminal. Heterodimers with TGFB1 and with TGFB2 have been found in bone. It was proved to have suppressive effects on interleukin-2 dependent T-cell growth. This antibody is TGFB2 specific not detecting other TGFBs.
|Product Specific Protocols|
|WB protocol for TGF-beta 2-Specific antibody 19999-1-AP||Download protocol|
|IHC protocol for TGF-beta 2-Specific antibody 19999-1-AP||Download protocol|
|IF protocol for TGF-beta 2-Specific antibody 19999-1-AP||Download protocol|
|Click here to view our Standard Protocols|
J Cell Mol Med
The role and mechanism of transforming growth factor beta 3 in human myocardial infarction-induced myocardial fibrosis.
Gender differences in fibrosis remodeling in patients with long-standing persistent atrial fibrillation.
TGF-β2 is involved in the preservation of the chondrocyte phenotype under hypoxic conditions.
Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGFβRIII-p38MAPK-pS249/T252RB pathway.
Int J Ophthalmol
EDIL3 depletion suppress epithelial-mesenchymal transition of lens epithelial cellsviatransforming growth factor β pathway.
Exp Ther Med
Expression of miR-181a and TGF-β2 in lens epithelial cells of patients with cataractous retinal detachment and its clinical significance.